Continued Level of Significant Insider Selling at AnaptysBio (ANAB)

Tuesday, August 08, 2017 10:15 PM ET

Continued Level of Significant Insider Selling at AnaptysBio (ANAB)

A notable insider sale of the shares of AnaptysBio was indicated in a form 4 document filed with the SEC today, showing — Novo A/S, 10% Owner — sold 491,294 shares in the company having a market value of approximately $10,377,406. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 70,706 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 562,000 shares and have averaged 281,000 shares per transaction over this time period.

Insider buy/sell trading at AnaptysBio is greater than the 263 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 319 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for AnaptysBio insiders was also higher. Within the peer group there were 7,348,988 shares purchased and 15,467,710 shares sold with company insiders disposing of 25,451 shares on average.

The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.